Vardenafil decreases bladder afferent nerve activity in unanesthetized, decerebrate, spinal cord-injured rats.
Behr-Roussel
Delphine
D
Pelvipharm, Orsay, France.
Oger
Stephanie
S
Caisey
Stéphanie
S
Sandner
Peter
P
Bernabé
Jacques
J
Alexandre
Laurent
L
Giuliano
Francois
F
D000818:Animals; D003655:Decerebrate State; D004195:Disease Models, Animal; D005260:Female; D007093:Imidazoles / Q000494:pharmacology*; D009475:Neurons, Afferent / Q000187:drug effects* / Q000502:physiology; D058986:Phosphodiesterase 5 Inhibitors / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology*; D011312:Pressure; D051381:Rats; D017207:Rats, Sprague-Dawley; D013119:Spinal Cord Injuries / Q000150:complications* / Q000503:physiopathology; D013126:Spinal Nerve Roots / Q000502:physiology; D013450:Sulfones / Q000494:pharmacology; D014227:Triazines / Q000494:pharmacology; D001743:Urinary Bladder / Q000294:innervation / Q000503:physiopathology; D053201:Urinary Bladder, Overactive / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D000069058:Vardenafil Dihydrochloride
D007093:Imidazoles; D058986:Phosphodiesterase 5 Inhibitors; D010879:Piperazines; D013450:Sulfones; D014227:Triazines; D000069058:Vardenafil Dihydrochloride